Yale’s Gray Matters Study Sheds Light on ADHD and Brain Development
Attention-Deficit/Hyperactivity Disorder (ADHD) affects millions of children and adults worldwide, often interfering with academic performance, relationships, and emotional regulation. While medication remains a common treatment, growing interest in non-pharmacological interventions has led to groundbreaking research efforts — one of the most prominent being the collaboration between Gray Matters Health and Yale University on a pioneering

